Xylem (XYL) Q3 2026 Earnings Call Transcript

Xylem reported Q3 revenue of $2.2 billion, flat organically, while orders rose 10% to $2.3 billion, backlog increased 13% to $5.5 billion, and adjusted EPS grew 5% to $1.44. It cut full-year 2026 organic revenue guidance from 2%-3% growth to roughly flat and adjusted EPS guidance from $5.55-$5.70 to $5.40-$5.45, citing slower utility spending and project conversion. Management plans to divest businesses representing about 9% of revenue but less than 5% of EBITDA and reorganize from four segments to three beginning Jan. 1, 2027; data center orders in Applied Water rose more than 200% in Q3.

Analysis

The key risk is not demand destruction but conversion quality: backlog growth is concentrated in projects scheduled well beyond the next few quarters, while near-term metering purchases are discretionary and large WSS jobs remain schedule-sensitive. That makes backlog a weaker earnings floor than the headline suggests. If utility affordability pressure persists, delayed replacements can become cancellations or smaller scopes, extending the recovery beyond management’s timing narrative. Meanwhile, AI construction competes for contractors and project capacity, creating a second-order bottleneck for Xylem’s own water-treatment deployments.

Data-center demand is strategically attractive but not yet a near-term earnings offset: management’s stated year-end revenue run rate remains modest, and capacity investment may pressure margins before utilization catches up. The planned divestitures should improve mix, but execution and reinvestment matter more than the portfolio label; proceeds are not expected to be available until late 2027/early 2028. The immediate read-through is therefore cautious despite resilient orders and margin execution.

Over the next 1–3 months, focus on project conversion, utility spending commentary, and February 2027 guidance—not order growth alone. Over 6–18 months, upside depends on MCS awards shipping on schedule, WSS projects converting, and data-center/microelectronics wins scaling without eroding margins. The contrarian risk to a bearish view is that durable repair-and-replace demand and productivity gains protect earnings while deferred projects return. Falsify the cautious thesis if quarterly organic revenue conversion improves without backlog slippage and management restores growth expectations; worsen it if guidance is cut again or backlog/order conversion deteriorates.

Key Decisions for Investors

• Keep XYL underweight versus diversified industrial exposure; avoid adding on order-growth headlines until conversion is visible. A tactical hedge on strength is preferable to an outright short given margin resilience and durable repair-and-replace demand.
• Use the February 2027 outlook as the key reassessment catalyst. Track MCS book-and-ship activity, water-metering backlog conversion, and WSS project milestones; repeated deferrals or another guidance reduction would support extending the underweight.
• Treat data-center exposure as a watch item, not a standalone reason to buy XYL: verify revenue contribution, capacity utilization, and incremental margins as the business scales. No direct AMZN trade is indicated by this call.
• Revisit the view if organic revenue conversion accelerates and backlog ships on schedule; become more defensive if utility affordability delays spread beyond discretionary metering or if project slippage persists into 2027.